KIROMIC BIOPHARMA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBPQ and buy or sell other stocks, ETFs, and their options commission-free!About KRBPQ
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani
CEOPietro Bersani
Employees44
Employees44
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees44
Employees44
KRBPQ Key Statistics
Market cap157.09
Market cap157.09
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.20
Average volume1.20
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.005
52 Week high$0.005
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 157.09, KIROMIC BIOPHARMA INC(KRBPQ) trades at $0.00.
On 2026-08-10, KIROMIC BIOPHARMA INC(KRBPQ) stock opened at —, reached a high of —, and a low of —.
The KIROMIC BIOPHARMA INC(KRBPQ)'s current trading volume is 0, compared to an average daily volume of 1.2.
During the past year, KIROMIC BIOPHARMA INC(KRBPQ) stock moved between $0.00 at its lowest and $0.01 at its peak.
During the past year, KIROMIC BIOPHARMA INC(KRBPQ) stock moved between $0.00 at its lowest and $0.01 at its peak.
People also own
Based on the portfolios of people who own KRBPQ. This list is generated using Robinhood data, and it’s not a recommendation.